Ali BAYRAM, Mustafa ŞAHİN, Murat DOĞAN, Cemil MUTLU

Do diabetic patients with Bell's palsy benefit from corticosteroids?

Bell palsili diyabet hastaları kortikosteroitlerdenfayda sağlar mı? Amaç: Bell palsili (BP) diyabet hastalarının steroid tedavisinden sağladığı yararı değerlendirmek.Yöntem:Bu retrospektif çalıflmada üç hasta grubu bulunmaktaydı.Grup I kortikosteroid tedavisi için hastaneye yatırılmıfl BP'li diyabethastalarını, Grup II tedavi rejiminin olumsuz etkileri hakkında bilgilendirildikten sonra steroid tedavisini reddeden hastaları içermekteydi. Yafl ve cinsiyete göre efllefltirilmifl, ayaktan steroid tedavisi görmüfl30 diyabetik olmayan BP hastası ise Grup III'ü oluflturuyordu. Yüzfelcinin bafllangıcında ve 12 ay sonra House-Brackmann (H-B) skorları, ortalama toparlanma süresi ve tatminkâr iyileflme gösteren hastasayısı gruplar arasında karflılafltırıldı. Bulgular:Çalıflma grupları arasında H-B derecesi, ortalama derlenme süresi, bafllangıçta ve yüz felcinden 12 ay sonra tatminkâr iyileflmeaçısından istatistiksel olarak anlamlı bir fark yoktu. Sonuç:BP'li diyabet hastalarında, kan flekeri ve kan basıncı düzeyleri düzenli medikal takiple ayarlandığı müddetçe steroid tedavisi uygulanmadan da yüz fonksiyonları tatminkâr derecede yeniden kazanılabilir

Objective: To evaluate the beneficial effect of steroid therapy in the treatment of diabetic patients with Bell's palsy (BP). Methods: There were three patient groups in the present retrospective study. Group I consisted of diabetic patients with BP who were hospitalized for corticosteroid treatment, whereas Group II was composed of diabetic patients with BP who refused to receive steroid therapy after being informed about the adverse effects of the regimen. Thirty ageand sex-matched non-diabetic BP patients treated with steroid therapy on an outpatient basis constituted Group III. House-Brackmann (H-B) grades at onset and 12 months after facial paralysis, mean complete recovery time and the number of patients who demonstrated satisfactory recovery were compared between the groups. Results: There was no statistically significant difference with regard to H-B grades, mean recovery time or number of patients with satisfactory recovery at onset and 12 months after facial paralysis among the study groups. Conclusion: In diabetic patients with BP, the recovery of facial functions may be satisfactory without steroid therapy as long as the regulation of blood sugar and blood pressure levels are ensured with regular medical follow-up.

PDF

___

Ford CN. Evaluation and management of laryngopharyngeal reflux. JAMA 2005;294:1534–40.
Katz PO. State of the art: extraesophageal manifestations of gastroesophageal reflux disease. Rev Gastroenterol Disord 2005;5: 126–34.
Landis BN, Konnerth CG, Hummel T. A study on the frequency of olfactory dysfunction. Laryngoscope 2004;114:1764–9.
Brämerson A, Johansson L, Ek L, Nordin S, Bende M. Prevalence of olfactory dysfunction: the Skövde population-based study. Laryngoscope 2004;114:733–7.
Klinkenberg-Knol EC. Otolaryngologic manifestations of gastrooesophageal reflux disease. Scand J Gastroenterol Suppl 1998;33 (225):24–8.
Habesoglu TE, Habesoglu M, Sürmeli M, et al. Histological changes of rat soft palate with exposure to experimental laryngopharyngeal reflux. Auris Nasus Larynx 2010;37:730–6.
Abdel-aziz MM, El-Fattah AM, Abdalla AF. Clinical evaluation of pepsin for laryngopharyngeal reflux in children with otitis media with effusion. Int J Pediatr Otorhinolaryngol 2013;77:1765–70 . Megale SR, Scanavini AB, Andrade EC, Fernandes MI, AnselmoLima WT. Gastroesophageal reflux disease: its importance in ear, nose, and throat practice. Int J Pediatr Otorhinolaryngol 2006;70: 81–8.
Phipps CD, Wood WE, Gibson WS, Cochran WJ. Gastroesophageal reflux contributing to chronic sinus disease in children: a prospective analysis. Arch Otolaryngol Head Neck Surg 2000;126: 831–6.
Toros SZ, Toros AB, Ozel L, et al. Investigation of gastric pepsinogen in middle ear fluid of children with glue ear. Acta Otolaryngol 2010;130:1220–4.
Tasker A, Dettmar PW, Panetti M, Koufman JA, P Birchall J, Pearson JP. Is gastric reflux a cause of otitis media with effusion in children? Laryngoscope 2002;112:1930–4.
Hellgren J, Olin AC, Torén K. Increased risk of rhinitis symptoms in subjects with gastroesophageal reflux. Acta Otolaryngol 2014; 134:615–9.
Weaver EM. Association between gastroesophageal reflux and sinusitis, otitis media, and laryngeal malignancy: a systematic review of the evidence. Am J Med 2003;115 Suppl 3A:81S–89S.
Barbero GJ. Gastroesophageal reflux and upper airway disease. Otolaryngol Clin North Am 1996;29:27–38.
Halstead LA. Role of gastroesophageal reflux in pediatric upper airway disorders. Otolaryngol Head Neck Surg 1999;120:208–14.
Contencin P, Narcy P. Nasopharyngeal pH monitoring in infants and children with chronic rhinopharyngitis. Int J Pediatr Otorhinolaryngol 1991;22:249–56.
Veyseller B, Ozucer B, Karaaltin AB, Yildirim Y, Degirmenci N, Aksoy F, Ozturan O. Connecticut (CCCRC) Olfactory test: normative values in 426 healthy volunteers. Indian J Otolaryngol Head Neck Surg 2014;66:31–4.
Günbey E, Gören ‹, Ünal R, Y›lmaz M. An evaluation of olfactory function in adults with gastro-esophageal reflux disease. Acta Otolaryngol 2016;136:214–8.
Emre Dinc M, Dalgic A, Avincsal MO, Ulusoy S, Celik A, Develioglu ON. An assessment of olfactory function in patients with laryngopharyngeal reflux disease. Acta Otolaryngol 2017;137: 71–7.